Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: A case report

Journal of Clinical Pathology

Volumn 58, Issue 8, 2005, Pages 884-887

  Tanaka, K ^a,a   Honna, T ^a   Kitano, Y ^a   Kuroda, T ^a   Morikawa, N ^a   Matsuda, H ^a   Kawashima, N ^a   Matsuoka, K ^a   Miyauchi, J ^a,b  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IODINATED POPPYSEED OIL; MONOCLONAL ANTIBODY; PIRARUBICIN;

ABDOMINAL PAIN; ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; CARCINOMA CELL; CASE REPORT; CELL DIFFERENTIATION; CELL SURFACE; COMPUTER ASSISTED TOMOGRAPHY; CYTOPLASM; DISEASE ASSOCIATION; DUODENUM TUMOR; FATIGUE; FEVER; FIBROLAMELLAR CARCINOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; LABORATORY TEST; LIVER CELL; LIVER CELL CARCINOMA; LIVER LOBECTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; STEM CELL; TUMOR LOCALIZATION; TUMOR RECURRENCE; WEIGHT REDUCTION;

ADOLESCENT; ANTIGENS, NEOPLASM; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASMS, MULTIPLE PRIMARY;

EID: 23444444701     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.021956     Document Type: Article

References (20)

1. Edmondson HA. Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. Am J Dis Child 1956;91:168-86.
2. Craig JR, Peters RL, Edmondson HA, et al. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinicopathologic features. Cancer 1980;46:372-9.
3. Berman MM, Libbey NP, Foster JH. Hepatocellular carcinoma, polygonal cell type with fibrous stroma: an atypical variant with a favorable prognosis. Cancer 1980;46:1448-55.
4. Farhi DC, Shikes RH, Murari PJ, et al. Hepatocellular carcinoma in young people. Cancer 1983;52:1516-25.
5. Berman MA, Burnham JA, Sheahan DG. Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol 1988;19:784-94.
6. Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellular- cholangiocarcinoma: a histologic and immunohistochemical study. Cancer 1985;55:124-35.
7. Maeda T, Adachi E, Kajiyama K, et al. Combined hepatocellular- cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol 1995;26:956-64.
8. Ng IO, Shek TW, Nicholls J, et al. Combined hepatocellular- cholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol 1998;13:34-40.
9. Anthony PP. Tumors of the hepatobiliary system. In: Fletcher CDM, ed. Diagnostic histopathology of tumors. London: Churchill Livingsotone, 2000:425.
10. Hirohashi S, Ishak KG, Kojiro M, et al. Hepatocellular carcinoma. In: Hamilton SR, Aaltonen LA, eds. WHO classification: tumors of the digestive system. Lyon: IARC Press, 2000:159-81.
11. Seifz G, Zimmermann A, Friess H, et al. Adult-type hepatocellular carcinoma in the center of a fibrolamellar hepatocellular carcinoma. Hum Pathol 2002;33:765-9.
12. Yamamoto H, Watanabe K, Nagata M, et al. Transformation of fibrolamellar carcinoma to common hepatocellular carcinoma in the recurrent lesions of the rectum and the residual liver: a case report. Jpn J Clin Oncol 1999;29:445-7.
13. Haratake J, Hashimoto H. An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma. Liver 1995;15:9-15.
14. Parcell AI, De Young BR, Proca DM, et al. Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers. Mod Pathol 2000;13:773-8.
15. Tsuji M, Kashihara T, Terada N, et al. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with α-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratin 18 and 19. Pathol Int 1999;49:310-17.
16. Hirohashi S, Shimosato Y, Ino Y, et al. Distrubution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma. Jpn J Clin Oncol 1983;13:37-43.
17. Lau SK, Prakash S, Gellar SA, et al. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol 2002;33:1175-81.
18. Chu PG, Ishizawa S, Wu E, et al. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol 2002;26:978-88.
19. Epstein BE, Pajak TF, Haulk TL. Metastatic nonresectable fibrolamellar hepatoma. Am J Clin Oncol 1999;22:22-8.
20. Pinna AD, Iwatsuki S, Lee RG, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997;26:877-83.